Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr;35(4):547-554.
doi: 10.1007/s00467-019-04207-9. Epub 2019 Feb 28.

Drug-induced tubulointerstitial nephritis: hypersensitivity and necroinflammatory pathways

Affiliations
Review

Drug-induced tubulointerstitial nephritis: hypersensitivity and necroinflammatory pathways

Allison A Eddy. Pediatr Nephrol. 2020 Apr.

Abstract

More than 250 drugs carry a small but important dose-independent risk of initiating a delayed-type hypersensitivity reaction that leads to acute tubulointerstitial nephritis (TIN). Clinical manifestations are often non-specific, making epidemiological studies challenging. In severe cases, if cessation of the offending drug is not followed by a prompt improvement in renal function, corticosteroid therapy appears to enhance renal recovery rates. Other drugs, classified as potential nephrotoxins, may induce dose-dependent acute tubular necrosis. Studies over the past decade have identified a unique form of tubular cell death called "necroptosis" that is accompanied by a specific and significant interstitial inflammatory response to certain insults, including some nephrotoxins. Insights into the molecular basis of this necroinflammatory pathway have emerged. There is still a paucity of pediatric data on these two distinct types of drug-induced TIN. Early recognition is essential to minimize the risk of chronic kidney damage.

Keywords: Acute kidney injury; Casts; Crystals; Eosinophiluria; Interstitial nephritis; Necroinflammation; Nephrotoxicity.

PubMed Disclaimer

References

    1. Nast CC (2017) Medication-induced interstitial nephritis in the 21st century. Adv Chronic Kidney Dis 24:72–79 - PubMed
    1. Perazella MA, Markowitz GS (2010) Drug-induced acute interstitial nephritis. Nat Rev Nephrol 6:461–470 - PubMed
    1. Paueksakon P, Fogo AB (2017) Drug-induced nephropathies. Histopathology 70:94–108 - PubMed
    1. Baker RJ, Pusey CD (2004) The changing profile of acute tubulointerstitial nephritis. Nephrol Dial Transplant 19:8–11 - PubMed
    1. Valluri A, Hetherington L, McQuarrie E, Fleming S, Kipgen D, Geddes CC, Mackinnon B, Bell S (2015) Acute tubulointerstitial nephritis in Scotland. QJM 108:527–532 - PubMed

Publication types

MeSH terms

Substances

Supplementary concepts

LinkOut - more resources